InvestorsObserver
×
News Home

Is Ideaya Biosciences Inc (IDYA) a Good Buy in the Healthcare Sector?

Tuesday, March 19, 2024 12:45 PM | InvestorsObserver Analysts

Mentioned in this article

Is Ideaya Biosciences Inc (IDYA) a Good Buy in the Healthcare Sector?

A rating of 82 puts Ideaya Biosciences Inc (IDYA) near the top of the Healthcare sector according to InvestorsObserver. Ideaya Biosciences Inc's score of 82 means that it ranks higher than 82% of stocks in the sector. In addition, its overall score of 84 ranks it higher than 84% of all stocks.

Overall Score - 84
IDYA has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on IDYA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 84 would rank higher than 84 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Ideaya Biosciences Inc Stock Today?

Ideaya Biosciences Inc (IDYA) stock is trading at $45.18 as of 12:36 PM on Tuesday, Mar 19, a rise of $1.72, or 3.96% from the previous closing price of $43.46. The stock has traded between $42.83 and $45.24 so far today. Volume today is below average. So far 173,494 shares have traded compared to average volume of 793,635 shares. Click Here to get the full Stock Report for Ideaya Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App